These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6544118)

  • 1. Liposomal methotrexate in the treatment of murine L1210 leukemia.
    Woo SY; Dilliplane P; Rahman A; Sinks LF
    Cancer Drug Deliv; 1983; 1(1):59-62. PubMed ID: 6544118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
    Bender RA; Nichols AP; Norton L; Simon RM
    Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK; Huang AT; Joines WT
    Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K; Robak T
    Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate.
    Weinstein JN; Magin RL; Cysyk RL; Zaharko DS
    Cancer Res; 1980 May; 40(5):1388-95. PubMed ID: 6892792
    [No Abstract]   [Full Text] [Related]  

  • 7. Microwave treatment of intracerebral L1210 leukemia: schedule-dependent partial reversal of the effects of methotrexate.
    Chang BK; Huang AT; Joines WT
    Bioelectromagnetics; 1981; 2(1):77-80. PubMed ID: 7284044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
    Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
    Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
    J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
    Chu BC; Howell SB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):389-93. PubMed ID: 6974776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of day of dosage omission on survival time in the regularly scheduled methotrexate (NSC-740) treatment of leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):25-30. PubMed ID: 5030806
    [No Abstract]   [Full Text] [Related]  

  • 16. Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.
    Liu T; Singh R; Rios Z; Bhushan A; Li M; Sheridan PP; Bearden SE; Lai JCK; Agbenowu S; Cao S; Daniels CK
    Cancer Lett; 2015 Feb; 357(1):231-241. PubMed ID: 25444929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro uptake and therapeutic application of liposome-encapsulated methotrexate in mouse hepatoma 129.
    Patel KR; Jonah MM; Rahman YE
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):833-43. PubMed ID: 6891330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination Chemotherapy of L1210 Tumors in Mice with Pretubulysin and Methotrexate Lipo-Oligomer Nanoparticles.
    Truebenbach I; Kern S; Loy DM; Höhn M; Gorges J; Kazmaier U; Wagner E
    Mol Pharm; 2019 Jun; 16(6):2405-2417. PubMed ID: 31025870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.